Showing results (51-60 of 136) with videos related to

Sort By:
Pageof 14
Leukemia & Lymphoma|August 14, 2014
Comparison of different DNA extraction methods from peripheral blood cells: advice from the Fondazione Italiana Linfomi Minimal Residual Disease NetworkClaudia Mannu, Anna Gazzola, Elena Ciabatti, et al.
British Journal of Haematology|July 14, 2011
Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemiaAndrea Rinaldi, Michael Mian, Ivo Kwee, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2016
Addition of Rituximab to Involved-Field Radiation Therapy Prolongs Progression-free Survival in Stage I-II Follicular Lymphoma: Results of a Multicenter StudyMarco Ruella, Andrea Riccardo Filippi, Riccardo Bruna, et al.
Bone Marrow Transplantation|August 23, 2019
Incidence and outcome of Kaposi sarcoma after hematopoietic stem cell transplantation: a retrospective analysis and a review of the literature, on behalf of infectious diseases working party of EBMTSimone Cesaro, Gloria Tridello, Steffie van der Werf, et al.
Frontiers in Oncology|February 27, 2023
Differences in the immunoglobulin gene repertoires of IgG versus IgA multiple myeloma allude to distinct immunopathogenetic trajectoriesGlykeria Gkoliou, Andreas Agathangelidis, Georgos Karakatsoulis, et al.
Blood|January 5, 2002
Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignanciesPaolo Corradini, Corrado Tarella, Attilio Olivieri, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2008
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesisFlavia Pichiorri, Sung-Suk Suh, Marco Ladetto, et al.
Blood|January 12, 2012
Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOPPatrizia Pregno, Annalisa Chiappella, Marilena Bellò, et al.
Internal and Emergency Medicine|January 8, 2020
Organizational determinants of hospital stay: establishing the basis of a widespread action on more efficient pathways in medical unitsGianmauro Numico, Roberta Bellini, Cristian Zanelli, et al.
Annals of Hematology|June 6, 2013
Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphomaSimone Ferrero, Luigia Monitillo, Barbara Mantoan, et al.
Pageof 14